Basic HTML Version
Assistant Editor: Special
Assignments
JULIA AALBERS
TEL: (021) 976-4378
FAX: 086 610 3395
e-mail: julia@clinicscardive.com
Development Editor:
GLENDA HARDY
CELL: 071 819 6425
FAX: 086 610 3395
e-mail: glenda@clinicscardive.com
Production Editor
SHAUNA GERMISHUIZEN
TEL: (021) 785-7178
FAX: 086 628 1197
e-mail: shauna@clinicscardive.com
Editorial Assistant and
Circulation
ELSABÉ BURMEISTER
TEL/FAX: (021) 976-8129
e-mail: elsabe@clinicscardive.com
Production Co-ordinator
WENDY WEGENER
TEL: (021) 976-4378
e-mail: wendy@clinicscardive.com
Content Manager
MICHAEL MEADON
(Design Connection)
TEL: (021) 975-3785
FAX: 0866 557 149
e-mail: michael@clinicscardive.com
The
South African Journal of
Diabetes and Vascular Disease
is
published four times a year for
Clinics Cardive Publishing (Pty)
Ltd and printed by Tandym
Print. Online Services: Design
Connection.
Articles in this Journal are
sourced as per agreement with
the British Journal of Diabetes
and Vascular Disease
All correspondence to be
directed to:
THE EDITOR
PO BOX 1013
DURBANVILLE
7551
or info@clinicscardive.com
TEL/FAX: (021) 976-8129
INT: 2721 976-8129
Full text articles available on:
www.diabetesjournal.co.za via
www.sabinet.co.za
The opinions, data and statements
that appear in any articles
published in this journal are those
of the contributors. The publisher,
editors and members of the
editorial board do not necessarily
share the views expressed herein.
Although every effort is made
to ensure accuracy and avoid
mistakes, no liability on the part of
the publisher, editors, the editorial
board or their agents or employees
is accepted for the consequences
of any inaccurate or misleading
information.
Reports
77
47th SEMDSA congress 2012
G Hardy
78
Vitamin D and human health: a magic bullet?
G Hardy
81
Novo Nordisk incretin leadership summit,
Cape Town
P Wagenaar, G Hardy, J Aalbers
Patient Leaflet
87
Exercise after anticoagulation of deep-vein
thrombosis
S Nel
88
Exercise and peripheral arterial disease
S Nel
Diabetes Educator’s Focus
89
Screening for peripheral arterial disease in
people with diabetes
G van Rensburg
Hands On
92
Practical guidance on insulin usage in the
hospital setting
A Kok
Drug Trends
98
Liraglutide launched in South Africa
J Aalbers
100
Saxagliptin (Onglyza) launched in South Africa
J Aalbers
Page 89
It's the
shell that
makes
safer.
Safety-Coated
R
81mg
The ORIGINAL low dose aspirin
for optimum cardio-protection
Hp
Each tablet contains Aspirin 81mg. Reg.No.: 29/2.7/0767
Pharmafrica (Pty) Ltd, 33 Hulbert Road, New Centre, Johannesburg 2001
Under licence from Goldshield Pharmaceuticals Ltd. U.K.
WIN AN IPAD!
Subscribe to SAJDVD Content alerts.
Go to www.diabetesjournal.co.za, look for the
‘New content alerts (free)’ option
under the service tab on the left. Fill in your
personal details and under ‘Category’ choose
'Basal bolus'.